FerroTraceTM for Colorectal Cancer

Phase 1 & 2

Waitlist Available

Led By George Chang

Research Sponsored by M.D. Anderson Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 5 years

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing a new method using magnetic particles and green dye to find important lymph nodes in patients with colorectal cancer. The goal is to improve detection of cancer spread and ensure safety by monitoring any side effects.

Eligible Conditions

Colorectal Cancer

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 5 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 5 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: FerroTraceTM (magnetic tracer)Experimental Treatment2 Interventions

a special type of fluorescent dye called indocyanine green (ICG) during surgery can help surgeons find the lymph nodes that the cancer is most likely to have spread to in colorectal cancer patients.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

indocyanine green (ICG)

2019

Completed Phase 3

~20

Do I qualify?Apply below to find out